RePORT International Resources

TB can be prevented and treated, but it is still a major cause of sickness and death in children and adolescents. Every year, more than one million young people get sick with TB. Young children are especially at risk of severe illness and even death, while teenagers are more likely to develop forms of TB that can be readily transmitted. There are still significant gaps in the detection, diagnosis, treatment, and prevention of TB. The role of health care workers in preventing, identifying, and managing TB in children and adolescents is critical. This eCourse provides practical guidance on key elements of TB management in children and adolescents. It is about 2.5 hours in length.

This course explores effective strategies for re-initiating TB treatment after interruption, with a focus on supportive, community-based care. Emphasizing the importance of tracing loss to follow-up (LFU) cases, it equips healthcare providers to manage cases and encourage treatment return. The course also highlights the need to extend LFU surveillance to other services, including diagnosis, social support, post-treatment monitoring, and care for people with latent TB or receiving palliative care‚ key to implementing a truly people-centred approach in Eastern Europe and Central Asia. Each course/module contains short (up to 10 minutes) video presentations from a speaker of the relevant course/module, the main presentation, and reading materials (glossary, lecture, and list of useful resources).

Passcode: .s=d9KMs

Developed by WHO “The purpose of the manual is to provide guidelines and supporting material for sites embarking on STEPS chronic disease risk factor surveillance.” While focus is non-communicable diseases useful information for communicable disease e.g., STEPS instrument.

The TB digital platform offers dashboards displaying global TB data—from overall trends to specific sources like prevalence surveys. It brings together data from all countries and makes it easier to access and understand through clear, user-friendly visuals.

In 2025, WHO initiated a process for building consensus to advance the earlier and optimal inclusion of pregnant and lactating women in TB therapeutic and vaccine trials. This toolkit supports TB researchers and trialists in implementing the approaches outlined in the 2025 WHO consensus statement. It offers guidance on the design, implementation, analysis, and monitoring of studies that include pregnant and lactating women, supplemented by case studies and practical resources.

The database provides the most up-to-date information on clinical trials, operational research, and other studies related to TB and MDR-TB.

The 25th meeting of the WHO Expert Committee on Selection and Use of Essential Medicines was held in Geneva, Switzerland, from 5 to 9 May 2025. The Committee considered a total of 59 applications, including 31 proposals for the addition of new medicines or medicine classes, 10 proposals for new indications for currently listed medicines, three proposals for the addition of new formulations of currently listed medicines, one proposal for the removal of a currently listed medicine, and 14 other applications relevant to the Model Lists and the WHO AWaRe classification of antibiotics. This report summarizes the evidence considered and the recommendations made by the Expert Committee in updating the WHO Model Lists of Essential Medicines.

The WHO Global Tuberculosis Programme's newsletter for World TB Day 2025, which highlights the theme "Yes! We Can End TB: Commit. Invest. Deliver." The newsletter calls for urgent action to turn global commitments into results, increase funding, and scale up interventions that are proven to be effective, especially for drug-resistant TB. It includes key messages from various global leaders, such as the WHO Director-General, Dr. Tedros, and author John Green, highlighting the need for solidarity and sustained momentum to end TB

This webinar, commemorating World TB Day 2026, covered global TB data, new guidelines, and calls to action.